EAGLE, Idaho, Dec. 01, 2023 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of affiliated home health, hospice, home care and senior living companies, today announced that it has acquired Southwestern Palliative Care and Hospice (“Southwestern”), which provides skilled hospice services in Yuma, Arizona.
“We are pleased to continue our growth in the state of Arizona, and complement our agencies in Southern Arizona,” said Brent Guerisoli, Chief Executive Officer of Pennant. “This acquisition further solidifies our commitment to these communities, and expands our ability to provide life-changing hospice services to residents of Yuma and its surrounding communities.” Guerisoli added.
“Southwestern has a deep connection to the community it serves, and its staff have touched countless lives since its inception,” added John Gochnour, President and Chief Operating Officer of Pennant. “We are honored to partner with the wonderful Southwestern team of skilled clinicians and compassionate caregivers in delivering life-changing hospice services to the residents of this community.” added Mr. Gochnour.
Mr. Guerisoli reaffirmed that Pennant continues to pursue opportunities to acquire high quality home health, hospice and senior living businesses throughout the United States.
About Pennant:
The Pennant Group, Inc. is a holding company of independent operating subsidiaries that provide healthcare services through 103 home health and hospice agencies and 51 senior living communities located throughout Arizona, California, Colorado, Idaho, Iowa, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin and Wyoming. Each of these businesses is operated by a separate, independent operating subsidiary that has its own management, employees and assets. References herein to the consolidated "company" and "its" assets and activities, as well as the use of the terms "we," "us," "its" and similar verbiage, are not meant to imply that The Pennant Group, Inc. has direct operating assets, employees or revenue, or that any of the home health and hospice businesses, senior living communities or the Service Center are operated by the same entity. More information about Pennant is available at www.pennantgroup.com.
Last Trade: | US$30.56 |
Daily Change: | -0.58 -1.86 |
Daily Volume: | 266,066 |
Market Cap: | US$923.160M |
November 06, 2024 November 01, 2024 September 30, 2024 August 06, 2024 August 01, 2024 |
Chimerix is on a mission to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases. The company is devoted to filling gaps in the treatment paradigm. Chimerix’s most advanced clinical-stage program is in development for H3 K27M-mutant glioma....
CLICK TO LEARN MORETerns Pharmaceuticals is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity. Terns’ pipeline contains three clinical stage development programs including GLP-1 receptor...
CLICK TO LEARN MOREEnd of content
No more pages to load
COPYRIGHT ©2023 HEALTH STOCKS HUB